Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Novartis
Teva
Queensland Health
Express Scripts
McKinsey
Merck
Accenture
AstraZeneca
US Army

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,547,776

« Back to Dashboard

Which drugs does patent 7,547,776 protect, and when does it expire?

Patent 7,547,776 protects OFORTA and is included in one NDA.

This patent has thirty patent family members in twenty countries.
Summary for Patent: 7,547,776
Title:Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%
Abstract:The present invention generally relates to a fludarabine-phosphate with a purity of at least 99.5%.
Inventor(s): Tilstam; Ulf (Berlin, DE), Schmitz; Thomas (Berlin, DE), Nickisch; Klaus (Berlin, DE)
Assignee: Bayer Schering Pharma Aktiengesellschaft (Berlin, DE)
Application Number:09/471,040
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 7,547,776

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sanofi Aventis Us OFORTA fludarabine phosphate TABLET;ORAL 022273-001 Dec 18, 2008 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,547,776

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 56 289Dec 11, 1997

Non-Orange Book US Patents Family Members for Patent 7,547,776

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,046,322 Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5% ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,547,776

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 231880 ➤ Sign Up
Austria 8617 ➤ Sign Up
Australia 2155099 ➤ Sign Up
Australia 739574 ➤ Sign Up
Canada 2313486 ➤ Sign Up
Czech Republic 20002159 ➤ Sign Up
Czech Republic 296366 ➤ Sign Up
Germany 29825173 ➤ Sign Up
Germany 59807096 ➤ Sign Up
Denmark 1047704 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Express Scripts
McKinsey
Fuji
Accenture
Daiichi Sankyo
Harvard Business School
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot